[The therapeutic dilemma of the early invasive bladder cancer].
Transitional tumours of the bladder are classically divided in superficial (lesions of the mucosa and the submucosa) and invasive (infiltrating the detrusor) cancers. However, the recurrence and progression rate of submucosal urothelial cancers is highly variable. Therefore, management of such neoplasias is very challenging, some patients requiring a cystectomy, whereas others can be managed less invasively with endoscopic resection eventually associated with intravesical chemotherapy. We review herein the prognostic factors which help us to orientate our patients. We also emphasize the importance of the subclassification of the micro-invasive stage, and its practicability, which is reliable and simple, as opposed to the general belief.
Caviezel
Alessandro
A
Service d'urologie, Département de chirurgie, HUG, 1211 Genève 14. alessandro.caviezel@hcuge.ch
Pelte
Marie-Françoise
MF
Fateri
Farchid
F
Iselin
Christophe
C
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015653:Cystectomy; D006801:Humans; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging / Q000379:methods*; D011379:Prognosis; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery